Skip to main content
NexgenRx Inc. (NEGXF)
OTCMKTS · Delayed Price · Currency is USD
0.2000
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT

NexgenRx Revenue

NexgenRx had revenue of 4.16M CAD in the quarter ending September 30, 2024, with 22.67% growth. This brings the company's revenue in the last twelve months to 16.11M, up 18.00% year-over-year. In the year 2023, NexgenRx had annual revenue of 13.85M with 8.33% growth.

Revenue (ttm)
16.11M CAD
Revenue Growth
+18.00%
P/S Ratio
1.27
Revenue / Employee
805.50K CAD
Employees
20
Market Cap
15.19M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.85M1.07M8.33%
Dec 31, 202212.78M939.94K7.94%
Dec 31, 202111.84M1.27M12.01%
Dec 31, 202010.57M1.03M10.82%
Dec 31, 20199.54M2.37M33.06%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Northwest Biotherapeutics 1.38M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

NexgenRx News

More News